| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.34 | 0.06 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |